New Zealand approves third Covid vaccine Novavax for those over 18

New Zealanders will soon be able to access a third type of Novavax vaccine following the government's confirmation.

Novovax vaccine
Novavax coronavirus vaccine (Photo: AP)
IANS Wellington
1 min read Last Updated : Mar 01 2022 | 12:39 PM IST

New Zealanders will soon be able to access a third type of Novavax vaccine following the government's confirmation.

Covid Response Minister Chris Hipkins said on Tuesday that Novavax will soon be available to New Zealanders aged 18 and over, Xinhua news agency reported.

"Novavax is a protein-based Covid vaccine and while the Pfizer Covid vaccine remains the preferred vaccine of most New Zealanders, for some people, the arrival of Novavax will be the extra incentive required to get vaccinated against Covid," Hipkins said in a statement.

New Zealand is already one of the most highly vaccinated countries in the world with 95 per cent of people aged 12 and over being vaccinated, Hipkins said.

The first doses are anticipated to arrive in New Zealand this month, and officials are working with Novavax to confirm the delivery schedule and rollout start date, he said.

--IANS

int/sks/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronDelta variant of coronavirusCoronavirus VaccineNew Zealand

First Published: Mar 01 2022 | 12:39 PM IST

Next Story